Gf Fund Management Co. Ltd. Ocular Therapeutix, Inc Transaction History
Gf Fund Management Co. Ltd.
- $5.51 Trillion
- Q3 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 3,743 shares of OCUL stock, worth $42,557. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,743
Previous 4,026
7.03%
Holding current value
$42,557
Previous $37.4 Million
17.12%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding OCUL
# of Institutions
235Shares Held
157MCall Options Held
1.24MPut Options Held
423K-
Vr Adviser, LLC New York, NY13.2MShares$150 Million23.37% of portfolio
-
Summer Road LLC West Palm Beach, FL12.6MShares$143 Million98.91% of portfolio
-
Deep Track Capital, LP Greenwich, CT11.9MShares$136 Million4.4% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$131 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.3MShares$117 Million1.64% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $875M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...